Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types.
Quest Diagnostics & Ultima Team Up to Tackle MRD & Whole Genome Sequencing
What You Should Know: Ultima Genomics, a developer of a revolutionary new ultra-high throughput sequencing architecture, and Quest Diagnostics, the nation’s leading provider of diagnostic information services,